Literature DB >> 34075368

Are low SARS-CoV-2 viral loads in infected children missed by RT-PCR testing?

.   

Abstract

Entities:  

Year:  2021        PMID: 34075368      PMCID: PMC8159172          DOI: 10.1016/j.lanepe.2021.100138

Source DB:  PubMed          Journal:  Lancet Reg Health Eur


× No keyword cloud information.
The household is the main source of infection of SARS-CoV-2, and in a case-ascertained study we investigated the importance of age in household transmission dynamics [1]. We found that serological testing was more sensitive than RT-PCR in detecting household attack rates, with equally high attack rates in children (48%) and young adults (42%), showing that a negative RT-PCR test does not exclude infection. We therefore read with interest the commentary by Forland and Aavitsland [2] which specifically discusses our findings of equally high attack rates in children and adults. This commentary discusses SARS-CoV-2 transmission studies using RT-PCR only, not serological assays, both from Iceland and in a meta-analysis of attack rates [3], [4]. Our study was performed at the start of the pandemic in Norway in an immunologically naïve population. Community transmission was very low (3.9:100,000 infected) during this period. Transmission outside the household was unlikely, as schools and nurseries were closed. Therefore, the family was the main, often only, source of infection in children. We found that nearly 90% of children had negative nasopharyngeal RT-PCR samples, yet they seroconverted 6 weeks later, confirming infection. The commentary proposes either poor sampling technique, or late testing, for the low RT-PCR positivity observed in children. However, the same nasopharyngeal sampling technique was used in children and adults, with a median time of testing 6 days after symptom debut, considered an optimal timing for RT-PCR testing. We believe that children simply had lower viral loads in the nasopharynx and therefore tested RT-PCR negative but were infected and seroconverted at 6-8 weeks. The emergence of the more transmissible B.1.1.7 variant causes higher virus loads in the airways [5]. This variant has recently become dominant in Norway, with young children and 10–20-year-olds now among the most important groups testing RT-PCR positive, probably due to viral loads above the detection limit in nasopharyngeal samples.

Author contribution

Both authors contributed equally.

Declaration of competing interest

The authors have nothing to disclose.
  4 in total

1.  Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.

Authors:  Zachary J Madewell; Yang Yang; Ira M Longini; M Elizabeth Halloran; Natalie E Dean
Journal:  JAMA Netw Open       Date:  2020-12-01

2.  Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study.

Authors:  Kanika Kuwelker; Fan Zhou; Bjørn Blomberg; Sarah Lartey; Karl Albert Brokstad; Mai Chi Trieu; Amit Bansal; Anders Madsen; Florian Krammer; Kristin Gi Mohn; Camilla Tøndel; Dagrunn Waag Linchausen; Rebecca J Cox; Nina Langeland
Journal:  Lancet Reg Health Eur       Date:  2021-03-31

3.  Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.

Authors:  Dan Frampton; Tommy Rampling; Aidan Cross; Heather Bailey; Judith Heaney; Matthew Byott; Rebecca Scott; Rebecca Sconza; Joseph Price; Marios Margaritis; Malin Bergstrom; Moira J Spyer; Patricia B Miralhes; Paul Grant; Stuart Kirk; Chris Valerio; Zaheer Mangera; Thaventhran Prabhahar; Jeronimo Moreno-Cuesta; Nish Arulkumaran; Mervyn Singer; Gee Yen Shin; Emilie Sanchez; Stavroula M Paraskevopoulou; Deenan Pillay; Rachel A McKendry; Mariyam Mirfenderesky; Catherine F Houlihan; Eleni Nastouli
Journal:  Lancet Infect Dis       Date:  2021-04-12       Impact factor: 25.071

4.  Spread of SARS-CoV-2 in the Icelandic Population.

Authors:  Daniel F Gudbjartsson; Agnar Helgason; Hakon Jonsson; Olafur T Magnusson; Pall Melsted; Gudmundur L Norddahl; Jona Saemundsdottir; Asgeir Sigurdsson; Patrick Sulem; Arna B Agustsdottir; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Gudmundur Georgsson; Olafia S Gretarsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Hilma Holm; Brynjar O Jensson; Aslaug Jonasdottir; Frosti Jonsson; Kamilla S Josefsdottir; Thordur Kristjansson; Droplaug N Magnusdottir; Louise le Roux; Gudrun Sigmundsdottir; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Arthur Löve; Gisli Masson; Ingileif Jonsdottir; Alma D Möller; Thorolfur Gudnason; Karl G Kristinsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  N Engl J Med       Date:  2020-04-14       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.